narciclasine has been researched along with trans-dihydronarciclasine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabrielsen, B; Groszek, G; Hollingshead, M; Huggins, JW; Kefauver, DF; Kirsi, JJ; Monath, TP; Pettit, GR; Schubert, EM; Shannon, WM | 1 |
| Crankshaw, DJ; Holloway, AC; Makaji, E; McNulty, J; Nair, JJ; Pandey, S; Thorat, A; Vurgun, N | 1 |
| Bonnet, SL; Nair, JJ; van Staden, J; Wilhelm, A | 1 |
1 review(s) available for narciclasine and trans-dihydronarciclasine
| Article | Year |
|---|---|
Antibacterial constituents of the plant family Amaryllidaceae.
Topics: Alkaloids; Amaryllidaceae; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Plant Extracts | 2017 |
2 other study(ies) available for narciclasine and trans-dihydronarciclasine
| Article | Year |
|---|---|
Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances.
Topics: Animals; Antiviral Agents; Encephalitis, Japanese; Isoquinolines; Mice; Mice, Inbred C57BL; Plants, Medicinal; RNA Viruses; Viral Plaque Assay; Viruses | 1992 |
Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent, and selective cancer cell growth inhibitor.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Crystallography, X-Ray; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Narcissus; Phenanthridines; Stereoisomerism | 2011 |